EVOLV-Rx: Automated Decision Support for Eliminating Low-Value Clinical Practices07182Automated, cross-source detection of low-value prescribing to reduce harm; scalable decision support for providers, payers, and hospitals.Technology TypeDigital HealthTechnology SubtypeHealthcare DataTherapeutic AreasEndocrinology and Metabolic DiseasesRespiratoryTherapeutic IndicationsDiabetesChronic Obstructive Pulmonary Disease (COPD)TagsAgingAlgorithmPersonalized MedicineLead InventorThomas RadomskiDepartmentMed-MedicineAll Tech InnovatorsThomas R. RadomskiTechnology Readiness Level4. Prototype testing and refinementDate Submitted2025-05-12CollectionsCardiometabolic
Vasculogenic Reprogramming for Diabetic Wound Healing and Ischemic Tissue Regeneration06874Vasculogenic reprogramming via Tissue Nanotransfection induces vasculogenic fibroblasts, boosting diabetic wound healing and ischemic tissue regeneration.Technology TypeTherapeutic ModalityTechnology SubtypeGene Therapy - DNATherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorChandan SenDepartmentMed-SurgeryAll Tech InnovatorsSujit Kumar MohantySashwati RoyChandan SenTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2024-09-16CollectionsCell & Gene TherapyRegenerative MedicineCardiometabolic
Microsphere-Based Therapy for Reversing New-Onset Autoimmune Diabetes01703Innovative antisense-loaded microspheres reverses new-onset autoimmune diabetes by downregulating CD40/CD80/CD86, modulating dendritic cells.Technology TypeTherapeutic ModalityTechnology SubtypeVaccine - subunit, recombinant, polysaccharide, or conjugateTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorNick GiannoukakisDepartmentMed-PathologyAll Tech InnovatorsNick GiannoukakisMassimo M. TruccoTechnology Readiness Level4. Pre-clinical developmentDate Submitted2008-04-17CollectionsCardiometabolic
New Approach to Combat Lithium-Induced Diabetes Insipidus04699Nrf2 activation via Bardoxolone methyl offers a novel Li-NDI therapy, reducing polyuria/polydipsia and protecting kidney health.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasNephrologyEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesChronic Kidney Disease (CKD)Lead InventorFrancisco SchopferDepartmentMed-Pharmacology and Chemical BiologyAll Tech InnovatorsSoma JobbagyFrancisco Jose Schopfer PhDDario A. Vitturi IglesiasDate Submitted2018-08-02CollectionsCardiometabolic
Virtual Health Coach Bridges Rural Cardiovascular Care Gaps06539A rural-focused virtual health coach delivers empathic, personalized cardiovascular coaching with home monitoring integration for chronic disease.Technology TypeDigital HealthTechnology SubtypeOther Digital HealthTherapeutic AreasCardiovascularEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesPulmonary arterial hypertension (PAH)Lead InventorJared MagnaniDepartmentMed-MedicineAll Tech InnovatorsBrian KaleidaJared William MagnaniDate Submitted2023-10-10CollectionsCardiometabolic
MPowerHub06448A device-agnostic mobile platform blending real-time glucose, activity, and adherence data with actionable, evidence-based behavior goals.Technology TypeDigital HealthTechnology SubtypeHealthcare DataTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesTagsConsumerLead InventorAnn-Marie RoslandDepartmentMed-MedicineAll Tech InnovatorsCarissa Ann LowAnn-Marie RoslandDate Submitted2023-07-05CollectionsCardiometabolic
Gene Therapy Targeting Type 2 Diabetes05593Gene therapy silences smad2 to boost insulin secretion and β-cell function, potentially reversing diet-induced diabetes.Technology TypeTherapeutic ModalityTechnology SubtypeGene Therapy - RNATherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorGeorge GittesDepartmentMed-SurgeryAll Tech InnovatorsGeorge K. GittesKrishna PrasadanTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2021-01-15CollectionsCell & Gene TherapyCardiometabolic
Osteoprotegerin Enhances Beta Cell Survival and Proliferation to Treat Diabetes02495Osteoprotegerin promotes human beta cell survival and growth, potentially reducing insulin dependence for diabetes treatment.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Discovery - TargetTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorRupangi VasavadaDepartmentMed-MedicineAll Tech InnovatorsRupangi VasavadaTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2011-06-03CollectionsCardiometabolic
Mixed Radiographic Contrast Agent and Acetic Acid for Pancreatic Infusion06417Novel infusion blends acetic acid with radiographic contrast to ablate exocrine pancreas while preserving islets, enabling targeted therapy.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasHepatologyEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorGeorge GittesDepartmentMed-SurgeryAll Tech InnovatorsGeorge K. GittesHannah Rinehardt MDTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2023-05-25CollectionsCardiometabolic
TightRate: New Mobile App Offers Remote Insulin Titration to Achieve Lasting Targeted Glucose Levels with Patients05546Remote insulin titration app TightRate adjusts doses via provider-directed algorithms to achieve stable, personalized glucose targets.Technology TypeMedical DeviceTechnology SubtypeMonitoring Medical DeviceTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesTagsAutoimmuneLead InventorDavid RometoDepartmentMed-MedicineAll Tech InnovatorsDavid A. RometoSandra Indacochea SobelDate Submitted2020-11-05CollectionsCardiometabolicWomen's & Reproductive Health
Cox4i1: A Novel Target for Diabetes Treatment03958Cox4i1 as metformin target reveals new diabetes therapies; enables screening for selective, first-in-class antidiabetic drugs.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Discovery - TargetTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorNathan YatesDepartmentMed-Cell BiologyAll Tech InnovatorsHarris B. Bell-TeminSteven James MullettNathan A. YatesDate Submitted2016-06-13CollectionsCardiometabolic
Virtual Patient Simulation of Diabetic Ketoacidosis02575Interactive web-based VPsim trains clinical decision-making for diabetic ketoacidosis using virtual patient scenarios and tailored feedback.Technology TypeDigital HealthTechnology SubtypeHealthcare DeliveryTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesTagsEducation TechnologyLead InventorGary TabasDepartmentMed-MedicineAll Tech InnovatorsGary Howard TabasDate Submitted2011-09-28CollectionsCardiometabolic
Nitrated-fatty Acids Modulation of Type II Diabetes01545Nitrated fatty acids improve type 2 diabetes by PPAR-γ modulation, boosting insulin sensitivity without typical TZD side effects.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasCardiovascularEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesLead InventorBruce FreemanDepartmentMed-Pharmacology and Chemical BiologyAll Tech InnovatorsBruce A. FreemanDate Submitted2007-08-01CollectionsCardiometabolic
Live Cell Imaging of Insulin01663A live-cell insulin tracking method uses mcTimer fluorescent probes to monitor insulin synthesis, trafficking, and secretion over 24 hours.Technology TypeLife Science Research ToolTechnology SubtypeOther Life Science Research ToolTherapeutic AreasEndocrinology and Metabolic DiseasesTherapeutic IndicationsDiabetesTagsMicroscopyLead InventorPeter DrainDepartmentMed-Cell BiologyAll Tech InnovatorsPeter Francis DrainDate Submitted2008-03-03CollectionsCardiometabolic